Prescription Compounding Drug Nandrolone Decanoate Recalled for Subpotency
Fagron, Inc. is recalling 2 containers of Nandrolone Decanoate USP used for prescription compounding because the product is subpotent, containing less active ingredient than expected. The recall is nationwide.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class III recall with no reported illnesses or injuries. The hazard is subpotency, a quality defect rather than an acute safety risk. The recall is voluntary and precautionary, meeting the Moderate criterion.
Plain-English summary
Fagron, Inc. is recalling 2 containers of Nandrolone Decanoate, USP (500 g each), a prescription compounding ingredient distributed by Humco under NDC 0395-8212-56. The affected lot is 18L12-U02-050018 with an expiration date of October 31, 2022.
The recall was initiated due to subpotency, meaning the product contains less active ingredient than expected. This quality issue could affect the therapeutic effectiveness of medications prepared using this ingredient.
The product was distributed nationwide throughout the United States to pharmacy compounding facilities and healthcare providers. This is a voluntary recall initiated by the manufacturer on March 4, 2022, and was terminated on July 14, 2024.
The recalled product
- Product
- Nandrolone Decanoate, USP, 500 g per plastic container, Rx Only, For Prescription Compounding, Distributed by: Humco, 7400 Alumax Road, Texarkana, TX 75501. NDC 0395-8212-56
- Manufacturer
- Fagron, Inc
- Category
- Drug — Prescription Compounding
- Hazard
- Affected units
- 2
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: 18L12-U02-050018
- Exp. Date 10/31/2022
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 5 recalled by Fagron, Inc under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 5 products in this recall →Related recalls
Same manufacturer · Fagron, Inc
See all →- HighNystatin Bulk Powder Recalled Due to Incorrect Label Strength
FDA (Drugs) · 2023-12-27
- HighNystatin Bulk Powder Recall for Incorrect Label Assay Value
FDA (Drugs) · 2023-12-27
- HighNystatin Powder Recall Due to Incorrect Assay Strength on Label
FDA (Drugs) · 2023-12-27
- HighNystatin bulk powder recall due to incorrect assay strength label
FDA (Drugs) · 2023-12-27
- ModerateFDA Recalls Subpotent Nandrolone Decanoate Compounding Ingredient
FDA (Drugs) · 2022-05-18
Same hazard · subpotency
See all →- ModerateGood Neighbor Pharmacy Earwax Removal Drug Recalled for Low Potency
FDA (Drugs) · 2026-07-22
- ModerateNystatin Cream Recall Due to Low Potency Test Results
FDA (Drugs) · 2026-07-22
- ModerateFoster & Thrive Carbamide Peroxide 6.5% Recalled for Subpotent Strength
FDA (Drugs) · 2026-07-22
- ModerateLeader Carbamide Peroxide Earwax Removal Kit Recalled for Subpotency
FDA (Drugs) · 2026-07-22
- ModerateMeijer Earwax Removal Kit Recalled for Subpotent Active Ingredient
FDA (Drugs) · 2026-07-22